AAAAAA
Results:
1-11
|
Results: 11
Authors:
Treon, SP
Mitsiades, C
Mitsiades, N
Young, G
Doss, D
Schlossman, R
Anderson, KC
Citation: Sp. Treon et al., Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies, J IMMUNOTH, 24(3), 2001, pp. 263-271
Authors:
Treon, SP
Agus, TB
Link, B
Rodrigues, G
Molina, A
Lacy, MQ
Fisher, DC
Emmanouilides, M
Richards, AI
Clark, B
Lucas, MS
Schlossman, R
Schenkein, D
Lin, B
Kimby, E
Anderson, KC
Byrd, JC
Citation: Sp. Treon et al., CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia, J IMMUNOTH, 24(3), 2001, pp. 272-279
Authors:
Hideshima, T
Chauhan, D
Schlossman, R
Richardson, P
Anderson, KC
Citation: T. Hideshima et al., The role of tumor necrosis factor alpha in the pathophysiology of human multiple myeloma: therapeutic applications, ONCOGENE, 20(33), 2001, pp. 4519-4527
Authors:
Stewart, AK
Vescio, R
Schiller, G
Ballester, O
Noga, S
Rugo, H
Freytes, C
Stadtmauer, E
Tarantolo, S
Sahebi, F
Stiff, P
Meharchard, J
Schlossman, R
Brown, R
Tully, H
Benyunes, M
Jacobs, C
Berenson, R
White, M
DiPersio, J
Anderson, KC
Berenson, J
Citation: Ak. Stewart et al., Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial, J CL ONCOL, 19(17), 2001, pp. 3771-3779
Authors:
Alyea, E
Weller, E
Schlossman, R
Canning, C
Webb, I
Doss, D
Mauch, P
Marcus, K
Fisher, D
Freeman, A
Parikh, B
Gribben, J
Soiffer, R
Ritz, J
Anderson, K
Citation: E. Alyea et al., T-cell-depleted allogeneic bone marrow transplantation followed by donor lymphocyte infusion in patients with multiple myeloma: induction of graft-versus-myeloma effect, BLOOD, 98(4), 2001, pp. 934-939
Authors:
Mitsiades, CS
Treon, SP
Mitsiades, N
Shima, Y
Richardson, P
Schlossman, R
Hideshima, T
Anderson, KC
Citation: Cs. Mitsiades et al., TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications, BLOOD, 98(3), 2001, pp. 795-804
Authors:
Orsini, E
Alyea, EP
Chillemi, A
Schlossman, R
McLaughlin, S
Canning, C
Soiffer, RJ
Anderson, KC
Ritz, J
Citation: E. Orsini et al., Conversion to full donor chimerism following donor lymphocyte infusion is associated with disease response in patients with multiple myeloma, BIOL BLOOD, 6(4), 2000, pp. 375-386
Authors:
Ladetto, M
Donovan, JW
Harig, S
Weller, E
Trojan, A
Poor, C
Schlossman, R
Anderson, KC
Gribben, JG
Citation: M. Ladetto et al., Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in multiple myeloma, BIOL BLOOD, 6(3), 2000, pp. 241-253
Authors:
Orsini, E
Alyea, EP
Schlossman, R
Canning, C
Soiffer, RJ
Chillemi, A
Neuberg, D
Anderson, KC
Ritz, J
Citation: E. Orsini et al., Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion, BONE MAR TR, 25(6), 2000, pp. 623-632
Authors:
Freedman, AS
Neuberg, D
Mauch, P
Soiffer, RJ
Anderson, KC
Fisher, DC
Schlossman, R
Alyea, EP
Takvorian, T
Jallow, H
Kuhlman, C
Ritz, J
Nader, LM
Gribben, JG
Citation: As. Freedman et al., Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma, BLOOD, 94(10), 1999, pp. 3325-3333
Authors:
Vescio, R
Schiller, G
Stewart, AK
Ballester, O
Noga, S
Rugo, H
Freytes, C
Stadtmauer, E
Tarantolo, S
Sahebi, F
Stiff, P
Meharchard, J
Schlossman, R
Brown, R
Tully, H
Benyunes, M
Jacobs, C
Berenson, R
DiPersio, J
Anderson, K
Berenson, J
Citation: R. Vescio et al., Multicenter phase III trial to evaluate CD34(+) selected versus unselectedautologous peripheral blood progenitor cell transplantation in multiple myeloma, BLOOD, 93(6), 1999, pp. 1858-1868
Risultati:
1-11
|